858 related articles for article (PubMed ID: 17208228)
1. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
2. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
3. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
[TBL] [Abstract][Full Text] [Related]
4. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
6. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
7. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
8. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
11. Presence of nerves and their receptors in mouse and human conjunctival goblet cells.
Diebold Y; Ríos JD; Hodges RR; Rawe I; Dartt DA
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2270-82. PubMed ID: 11527940
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
Stern ME; Gao J; Schwalb TA; Ngo M; Tieu DD; Chan CC; Reis BL; Whitcup SM; Thompson D; Smith JA
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2609-14. PubMed ID: 12147592
[TBL] [Abstract][Full Text] [Related]
13. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
Jabs DA; Prendergast RA
Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
[TBL] [Abstract][Full Text] [Related]
14. Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.
Skarstein K; Holmdahl R; Johannessen AC; Jonsson R
Immunology; 1994 Apr; 81(4):497-501. PubMed ID: 8039804
[TBL] [Abstract][Full Text] [Related]
15. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
17. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
18. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
[TBL] [Abstract][Full Text] [Related]
19. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
20. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
